ijms-logo

Journal Browser

Journal Browser

Pathophysiology and Treatment of Nemaline Myopathy

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".

Deadline for manuscript submissions: 30 September 2024 | Viewed by 43

Special Issue Editor


E-Mail Website
Guest Editor
Department of Cellular and Molecular Medicine, University of Arizona, 1656 East Mabel Street, Tucson, AZ 85724-5217, USA
Interests: nebulin; titin; nemaline myopathy; titinopathy; HMERF; congenital myopathies; sarcomere dynamics; regulation of muscle contraction; myofilament

Special Issue Information

Dear Colleagues,

Over the last few decades, we have made great progress in identifying the genetic mutations that cause nemaline myopathy. We have also started to understand how some of these mutations result in muscle weakness through their disruption of the normal myofilament function, but much more work remains to be carried out. The connection between the causative mutations and muscle hypotrophy/atrophy remains largely obscure. Furthermore, there are currently no approved therapies targeting the underlying pathological processes that result in muscle weakness and muscle smallness. This unmet need represents a considerable burden for patients and their families. With these issues in mind, we are excited to announce a Special Issue of the International Journal of Molecular Science (IJMS) entitled “Pathophysiology and Treatment of Nemaline Myopathy”, which will focus on the molecular mechanisms that contribute to the disease phenotype and new innovative therapeutic approaches for nemaline myopathy. Since IJMS is a journal of molecular science, pure clinical or model studies will not be suitable for our journal. However, clinical or pure model submissions with biomolecular experiments are welcomed.

Dr. Johan Lindqvist
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • nemaline myopathy
  • hereditary neuromuscular disorder
  • genetic mutations
  • pathogenesis
  • pathophysiology
  • therapy
  • myofilament dysfunction

Published Papers

This special issue is now open for submission.
Back to TopTop